Isoniazid-resistant tuberculous meningitis, United States, 1993-2005

Emerging Infectious Diseases

Volumn 17, Issue 3, 2011, Pages 539-542

  Vinnard, Christopher ^a   Winston, Carla A ^b   Paul Wileyto, E ^a   Macgregor, Rob Roy ^a   Bisson, Gregory P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; STREPTOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG RESISTANT TUBERCULOSIS; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; TUBERCULOUS MENINGITIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INFANT; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED STATES; YOUNG ADULT;

EID: 79952341561     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1703.101715     Document Type: Article

References (10)

1. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160-70.
2. Vinnard C, Winston CA, Wileyto EP, Macgregor R, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: a retrospective cohort study. BMJ. 2010;341:c4451. DOI: 10.1136/bmj.c4451
3. Centers for Disease Control and Prevention. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1-77. Erratum in: MMWR Recomm Rep. 2005;53:1203. Medline
4. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, et al. The infl uence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008;4:e1000034. DOI: 10.1371/journal.ppat.1000034
5. Hoopes AJ, Kammerer JS, Harrington TA, Ijaz K, Armstrong LR. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003. Arch Intern Med. 2008;168:1984-92. DOI: 10.1001/ archinte.168.18.1984
6. Little R, Rubin D. Statistical analysis with missing data. New York: Wiley; 1987.
7. Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, et al. Tuberculous meningitis in patients infected with the human immunodefi ciency virus. N Engl J Med. 1992;326:668-72. DOI: 10.1056/NEJM199203053261004
8. French CE, Glynn JR, Kruijshaar ME, Ditah IC, Delpech V, Abubakar I. The association between HIV and antituberculosis drug resistance. Eur Respir J. 2008;32:718-25. DOI: 10.1183/09031936.00022308
9. Centers for Disease Control and Prevention. Mortality among patients with tuberculosis and associations with HIV status-United States, 1993-2008. Morb Mortal Wkly Rep. MMWR. 2010;59: 1509-13.
10. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis. 2009;48:179-85. DOI: 10.1086/595689